Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Pais

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
American Heart Journal|August 5, 2019
Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trialRajnish Joshi, Twinkle Agrawal, Farah Fathima, et al.
Journal of the American College of Cardiology|May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyBenjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
Indian Heart Journal|August 26, 2015
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic reviewMangala Rao, Denis Xavier, Padmini Devi, et al.
Lancet (London, England)|April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry dataDenis Xavier, Prem Pais, P J Devereaux, et al.
American Heart Journal|October 21, 2018
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductPhilip Joseph, Prem Pais, Antonio L Dans, et al.
American Heart Journal|April 1, 2009
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Hertzel C Gerstein, et al.
Indian Heart Journal|October 4, 2005
Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2Dorairaj Prabhakaran, Salim Yusuf, Shamir Mehta, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
American Heart Journal|August 5, 2019
Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trialRajnish Joshi, Twinkle Agrawal, Farah Fathima, et al.
Journal of the American College of Cardiology|May 7, 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyBenjamin M Scirica, Christopher P Cannon, Håkan Emanuelsson, et al.
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
Indian Heart Journal|August 26, 2015
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic reviewMangala Rao, Denis Xavier, Padmini Devi, et al.
Lancet (London, England)|April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry dataDenis Xavier, Prem Pais, P J Devereaux, et al.
American Heart Journal|October 21, 2018
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductPhilip Joseph, Prem Pais, Antonio L Dans, et al.
American Heart Journal|April 1, 2009
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Hertzel C Gerstein, et al.
Indian Heart Journal|October 4, 2005
Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2Dorairaj Prabhakaran, Salim Yusuf, Shamir Mehta, et al.
Heart (British Cardiac Society)|January 28, 2021
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseMatthias Bossard, Peggy Gao, William Boden, et al.
Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.
Pageof 11